Expert Perspectives – Managing Newly Diagnosed mCRPC – MOC Section 1

By the end of this module, the learner will be able to:

1. Describe the changing role of abiraterone and enzalutamide in the treatment of mCRPC.
2. Cite the suggested frequency of follow-up appointments in patients newly diagnosed with mCRPC.
3. List the healthcare professionals who play a role in the multidisciplinary approach to management of mCRPC.